article thumbnail

Illumina Acquires GRAIL For $8 Billion

socalTECH

Illumina said the buy will help it add a multi-disciplinary team and capabilities for next generation sequencing (NGS), population scale clinical studies, and machine learning. GRAIL is developing a multi-cancer screening test. GRAIL was spun out of Illumina in 2016 as a standalone company. billion in cash and $4.5

article thumbnail

The Pan-Cancer Screen: Still Early for Prime Time

Xconomy

I would be ecstatic to have a simple tool for my patients that could detect cancers like ovarian and pancreatic that currently have no effective screening approach. The most popular approach is screening blood for circulating tumor DNA (ctDNA), which several companies claim to reliably detect at very low levels in the blood.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aspen Neuroscience Gets $70M

socalTECH

The company said the Series A funding will support the completion of all remaining IND-enabling studies and FDA submission of the IND relating to Aspen's lead product (ANPD001), as well as the recruitment and screening of a trial-ready cohort of persons with Parkinson disease and the manufacture of their cells for the lead product.

San Diego 113
article thumbnail

New Study: DNA Tests For Healthy People Have “Uncertain Value”

Xconomy

A new study published Monday in the Annals of Internal Medicine questions the practicality of making DNA tests standard for people who don’t have a cancer diagnosis or aren’t trying to identify a mysterious disease. The study is limited by its small scope, but it is the first with some rigor to examine outcomes.

Study 62
article thumbnail

uSamp Ties With GutCheck

socalTECH

uSamp said it will provide automated deliver of screened and qualified participants to GutCheck's online qualitative market research studies. Encino-based uSamp , the provider of technology and services for the online panel and surveying market, said that it has teamed with GutCheck , a provider of online qualitative research.

Encino 140
article thumbnail

Scanwell Health launches smartphone tests for UTIs in partnership with Lemonaid Health

TechCrunch LA

The company has a test for chronic kidney disease in the works through a collaboration with Kaiser Permanent and the Chronic Renal Insufficiency Cohort Study to improve screening for and monitoring of chronic kidney disease at home. “We believe in the power of telehealth and what it can do,” says Chen.

Screening 148
article thumbnail

The Future of Advertising will be Integrated

Both Sides of the Table

In the IAB study that revealed the graph above, brand advertisers indicated that their number one objective in online advertising was “creating awareness&# followed by “creating purchase intent&# or “likelihood to recommend&# the product. As evidenced by the eye-tracking studies – they will remain in the stream.